T63534 |
PPTN hydrochloride
|
1992047-65-0
|
98%
|
|
PPTN hydrochloride is a potent, high-affinity, competitive, highly selective P2Y14 receptor antagonist (KB: 434 pM), but no agonist or antagonist activity at P2Y...
|
T34280 |
Regrelor disodium
|
676251-22-2
|
98%
|
|
Regrelor disodium is a p2y12 receptor antagonist that prevents thrombosis, effectively inhibits vascular smooth muscle cell contraction, inhibits cell proliferat...
|
T12530 |
PPTN
|
1160271-30-6
|
98%
|
|
PPTN is a high-affinity, competitive and highly selective antagonist of P2Y14 receptor(KB value of 434 pM), with anti-inflammatory and immune activity.
|
T4132 |
BPTU
|
870544-59-5
|
98%
|
|
Allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM). Non-nucleotide ligand. Binds receptor outside of the helical bundle. Blocks inhibition of spontaneous contrac...
|
T7423 |
Diquafosol tetrasodium
|
211427-08-6
|
98%
|
|
Diquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability...
|
T12164 |
N6-(4-Hydroxybenzyl)adenosine
|
110505-75-4
|
98%
|
|
N6-(4-Hydroxybenzyl)adenosine is a platelet aggregation inhibitor.
|
T5036 |
Cangrelor tetrasodium
|
163706-36-3
|
98%
|
|
Cangrelor tetrasodium is a reversible and selective antagonist of platelet P2Y12, with prompt and potent antiplatelet effects.
|
T21059 |
Ticagrelor metabolite M5
|
1251765-07-7
|
98%
|
|
Ticagrelor metabolite M5 is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor. Compared to Clopidogrel, Ticagrelor has faster an...
|
T23164 |
PIT
|
56583-49-4
|
98%
|
|
PIT is a specific and non-competitive antagonist of the Purinergic receptor P2Y1 with an IC50 of 0.14 μM for human P2Y1. PIT does not affect nucleotide binding a...
|
T0182 |
Clopidogrel
|
113665-84-2
|
98%
|
|
Clopidogrel, a P2Y12 receptor antagonist, decreases platelet aggregation.
|
T3536 |
AZD1283
|
919351-41-0
|
98%
|
|
AZD1283 is an effective P2Y12 receptor antagonist (EC50: 3.0 ug/kg/min, binding IC50: 11 nM). AZD1283 dose-dependently induced increases in blood flow and inhibi...
|
T11177 |
Elinogrel
|
936500-94-6
|
98%
|
|
Elinogrel is a competitive and reversible antagonist of platelet P2Y12 with IC50 of 20 nM and exhibits potent antiplatelet effects.
|
T8582 |
1-[(5-methylisoxazol-3-yl)methyl]piperazine
|
173850-51-6
|
98%
|
|
Piperazine, 1-[(5-methyl-3-isoxazolyl)methyl]- (9CI) is a P2Y12 inhibitor.
|
T0179 |
Ticagrelor
|
274693-27-5
|
98%
|
|
Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The ...
|
T6172 |
MRS 2578
|
711019-86-2
|
98%
|
|
MRS2578, an effective P2Y6 receptor antagonist with IC50 of 37 nM, shows insignificant inhibition at P2Y1, P2Y2, P2Y4, and P2Y11 receptors.
|
T0182L2 |
(±) Clopidogrel hydrogen sulfate
|
135046-48-9
|
98%
|
|
Clopidogrel, an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cere...
|
T4706 |
Uridine-5'-diphosphate disodium salt
|
27821-45-0
|
98%
|
|
UDP is a specific agonist of the P2Y6 receptors (EC50 = 13 nM for human P2Y6), stimulating the production of inflammatory mediators, phagocytosis, and vasoconstr...
|
T0230 |
Prasugrel
|
150322-43-3
|
98%
|
|
Prasugrel is a piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANG...
|
T0182L |
Clopidogrel hydrogen sulfate
|
120202-66-6
|
98%
|
|
(S)-(+)-Clopidogrel hydrogensulfate, a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and ...
|
T6952 |
Prasugrel Hydrochloride
|
389574-19-0
|
98%
|
|
Prasugrel hydrochloride is a piperazine derivative and pletelet aggregation inhibitor that is used to prevent thrombosis in patients with acute coronary syndrome...
|